Vivesto

Vivesto Liabilities

The The Liabilities of Vivesto (VIVE.ST) as of Oct 17, 2026 is 24.46 M SEK. In the previous year, The Liabilities was 14.55 M SEK — a change of 68.09% (higher).

Liabilities

24.46 MSEK

YoY

68.09%

Last updated:

In 2025, Vivesto's total liabilities amounted to 24.46 M SEK, a 68.09% difference from the 14.55 M SEK total liabilities in the previous year.

The Vivesto Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Liabilities
Date
Liabilities
Jan 1, 2018
222.33 M SEK
Jan 1, 2019
185.96 M SEK
Jan 1, 2020
176.80 M SEK
Jan 1, 2021
44.60 M SEK
Jan 1, 2022
30.45 M SEK
Jan 1, 2023
22.87 M SEK
Jan 1, 2024
14.55 M SEK
Jan 1, 2025
24.46 M SEK
The Vivesto Liabilities history
YEARLiabilitiesYoY
24.46 MSEK+68.09%
14.55 MSEK-36.38%
22.87 MSEK-24.89%
30.45 MSEK-31.71%
44.60 MSEK-74.78%
176.80 MSEK-4.92%
185.96 MSEK-16.36%
222.33 MSEK-0.32%
223.04 MSEK+0.83%
221.21 MSEK+16.72%
189.53 MSEK+36.49%
138.86 MSEK—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Vivesto Stock analysis

What does Vivesto do? Oasmia Pharmaceutical AB is a Swedish pharmaceutical company that specializes in the development and marketing of innovative cancer and pain medications. The company was founded in 1998 and is headquartered in Uppsala, Sweden. Vivesto is one of the most popular companies on Eulerpool.

Liabilities Details

Assessing Vivesto's Liabilities

Vivesto's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Vivesto's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Vivesto's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Vivesto's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Vivesto’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Vivesto stock

The Liabilities of Vivesto is 24.46 M SEK in 2025.

The Liabilities of Vivesto changed from 14.55 M SEK to 24.46 M SEK, representing a 68.09% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of The Liabilities Vivesto since 2006 – with annual values, charts, and detailed analysis.

The Liabilities's SEK is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Liabilities's Vivesto historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Vivesto

All Key Metrics — Vivesto